{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:17:03Z","timestamp":1790630223784,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Natural Science Foundation of Hebei Province of China","award":["H2019206664"],"award-info":[{"award-number":["H2019206664"]}]},{"name":"The focal point Project of Hebei medical research","award":["20170698"],"award-info":[{"award-number":["20170698"]}]},{"name":"Talent Engineering Training Project of Hebei Province","award":["201901035"],"award-info":[{"award-number":["201901035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10620-020-06690-9","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T05:06:58Z","timestamp":1605589618000},"page":"3391-3403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long Non-coding RNA LINC01503 Promotes Gastric Cardia Adenocarcinoma Progression via miR-133a-5p\/VIM Axis and EMT Process"],"prefix":"10.1007","volume":"66","author":[{"given":"Yanli","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"6690_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semradonc.2012.09.008","volume":"23","author":"MF Buas","year":"2013","unstructured":"Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23:3\u20139.","journal-title":"Semin Radiat Oncol"},{"key":"6690_CR2","first-page":"577","volume":"180","author":"S Ohno","year":"1995","unstructured":"Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg. 1995;180:577\u2013582.","journal-title":"J Am Coll Surg"},{"key":"6690_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00000658-200009000-00007","volume":"232","author":"J Rudiger Siewert","year":"2000","unstructured":"Rudiger Siewert J, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical\/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232:353\u2013361.","journal-title":"Ann Surg"},{"key":"6690_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00000658-198007000-00010","volume":"192","author":"DN Papachristou","year":"1980","unstructured":"Papachristou DN, Fortner JG. Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg. 1980;192:58\u201364.","journal-title":"Ann Surg"},{"key":"6690_CR5","first-page":"423","volume":"59","author":"Y Nakane","year":"1993","unstructured":"Nakane Y, Okamura S, Boku T, Okusa T, Tanaka K, Hioki K. Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach. Am Surg. 1993;59:423\u2013429.","journal-title":"Am Surg"},{"key":"6690_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3748\/wjg.v9.i6.1156","volume":"9","author":"LD Wang","year":"2003","unstructured":"Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol. 2003;9:1156\u20131164.","journal-title":"World J Gastroenterol"},{"key":"6690_CR7","first-page":"1","volume":"182","author":"M Vial","year":"2010","unstructured":"Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1\u201317.","journal-title":"Recent Results Cancer Res"},{"key":"6690_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/gutjnl-2015-309340","volume":"65","author":"N Hu","year":"2016","unstructured":"Hu N, Wang Z, Song X, et al. Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut. 2016;65:1611\u20131618.","journal-title":"Gut"},{"key":"6690_CR9","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1002\/cam4.2497","volume":"8","author":"E Abdi","year":"2019","unstructured":"Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Pourfarzi F. Risk factors predisposing to cardia gastric adenocarcinoma: insights and new perspectives. Cancer Med. 2019;8:6114\u20136126.","journal-title":"Cancer Med"},{"key":"6690_CR10","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965\u20133981.","journal-title":"Cancer Res"},{"key":"6690_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1756-8722-6-37","volume":"6","author":"H Zhang","year":"2013","unstructured":"Zhang H, Chen Z, Wang X, Huang Z, He Z, Chen Y. Long non-coding RNA: a new player in cancer. J Hematol Oncol. 2013;6:37.","journal-title":"J Hematol Oncol"},{"key":"6690_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29:452\u2013463.","journal-title":"Cancer Cell"},{"key":"6690_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253\u20131261.","journal-title":"Nat Med"},{"key":"6690_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155\u2013159.","journal-title":"Nat Rev Genet"},{"key":"6690_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353\u2013358.","journal-title":"Cell"},{"key":"6690_CR16","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.2147\/OTT.S189471","volume":"12","author":"J Hu","year":"2019","unstructured":"Hu J, Ni G, Mao L, et al. LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665\/AKT3 axis. Onco Targets Ther. 2019;12:7865\u20137875.","journal-title":"Onco Targets Ther"},{"key":"6690_CR17","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.2147\/OTT.S214588","volume":"12","author":"H Qi","year":"2019","unstructured":"Qi H, Xiao Z, Wang Y. Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p\/RNF2 axis. Onco Targets Ther. 2019;12:6981\u20136990.","journal-title":"Onco Targets Ther"},{"key":"6690_CR18","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/mc.22806","volume":"57","author":"W Guo","year":"2018","unstructured":"Guo W, Lv P, Liu S, et al. Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma. Mol Carcinog. 2018;57:854\u2013865.","journal-title":"Mol Carcinog"},{"key":"6690_CR19","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/mc.22650","volume":"56","author":"W Guo","year":"2017","unstructured":"Guo W, Dong Z, Liu S, et al. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma. Mol Carcinog. 2017;56:1924\u20131934.","journal-title":"Mol Carcinog"},{"key":"6690_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10585-016-9794-x","volume":"33","author":"W Guo","year":"2016","unstructured":"Guo W, Dong Z, Shi Y, et al. Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma. Clin Exp Metastasis. 2016;33:497\u2013508.","journal-title":"Clin Exp Metastasis"},{"key":"6690_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10120-019-00924-0","volume":"22","author":"W Guo","year":"2019","unstructured":"Guo W, Liang X, Liu L, et al. MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression. Gastric Cancer. 2019;22:705\u2013722.","journal-title":"Gastric Cancer"},{"key":"6690_CR22","first-page":"6445","volume":"23","author":"YK Qu","year":"2019","unstructured":"Qu YK, Qu XS, Chen G, et al. LINC01503 promotes cell proliferation, invasion and EMT process in cholangio-carcinoma. Eur Rev Med Pharmacol Sci. 2019;23:6445\u20136452.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6690_CR23","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1053\/j.gastro.2018.02.018","volume":"154","author":"JJ Xie","year":"2018","unstructured":"Xie JJ, Jiang YY, Jiang Y, et al. Super-enhancer-driven long non-coding RNA LINC01503, regulated by TP63, is over-expressed and oncogenic in squamous cell carcinoma. Gastroenterology. 2018;154:2137\u20132151,e2131.","journal-title":"Gastroenterology"},{"key":"6690_CR24","first-page":"4879","volume":"16","author":"SR Lu","year":"2018","unstructured":"Lu SR, Li Q, Lu JL, Liu C, Xu X, Li JZ. Long non-coding RNA LINC01503 promotes colorectal cancer cell proliferation and invasion by regulating miR-4492\/FOXK1 signaling. Exp Ther Med. 2018;16:4879\u20134885.","journal-title":"Exp Ther Med"},{"key":"6690_CR25","first-page":"1600","volume":"23","author":"H Wang","year":"2019","unstructured":"Wang H, Sheng ZG, Dai LZ. Long non-coding RNA LINC01503 predicts worse prognosis in glioma and promotes tumorigenesis and progression through activation of Wnt\/beta-catenin signaling. Eur Rev Med Pharmacol Sci. 2019;23:1600\u20131609.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6690_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06215-4","author":"J Ding","year":"2020","unstructured":"Ding J, Shi F, Xie G, Zhu Y. Long non-coding RNA LINC01503 promotes gastric cancer cell proliferation and invasion by regulating Wnt signaling. Dig Dis Sci. 2020; https:\/\/doi.org\/10.1007\/s10620-020-06215-4.","journal-title":"Dig Dis Sci"},{"key":"6690_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u2013408.","journal-title":"Methods"},{"key":"6690_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-017-0702-z","volume":"16","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liu Z, Yao B, et al. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2\/miR-367\/FBXW7 axis. Mol Cancer. 2017;16:123.","journal-title":"Mol Cancer"},{"key":"6690_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15384047.2019.1665393","volume":"21","author":"L Zheng","year":"2020","unstructured":"Zheng L, Kang Y, Zhang L, Zou W. MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR. Cancer Biol Ther. 2020;21:34\u201342.","journal-title":"Cancer Biol Ther"},{"key":"6690_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bbrc.2019.04.108","volume":"513","author":"T Wang","year":"2019","unstructured":"Wang T, Wang X, Du Q, Wu N, Liu X, Chen Y, Wang X. The circRNA circP4HB promotes NSCLC aggressiveness and metastasis by sponging miR-133a-5p. Biochem Biophys Res Commun. 2019;513:904\u2013911.","journal-title":"Biochem Biophys Res Commun"},{"key":"6690_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41419-020-02785-3","volume":"11","author":"L Yin","year":"2020","unstructured":"Yin L, Chen J, Ma C, et al. Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3. Cell Death Dis. 2020;11:562.","journal-title":"Cell Death Dis"},{"key":"6690_CR32","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1242\/jcs.112.24.4615","volume":"112","author":"C Gilles","year":"1999","unstructured":"Gilles C, Polette M, Zahm JM, et al. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999;112:4615\u20134625.","journal-title":"J Cell Sci"},{"key":"6690_CR33","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1159\/000358692","volume":"33","author":"Y Wang","year":"2014","unstructured":"Wang Y, Gao S, Liu G, Jia R, Fan D, Feng X. Microarray expression profile analysis of long non-coding RNAs in human gastric cardiac adenocarcinoma. Cell Physiol Biochem. 2014;33:1225\u20131238.","journal-title":"Cell Physiol Biochem"},{"key":"6690_CR34","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13167-019-00175-0","volume":"10","author":"N Li","year":"2019","unstructured":"Li N, Zhan X. Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer. EPMA J. 2019;10:273\u2013290.","journal-title":"EPMA J"},{"key":"6690_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tibs.2016.07.003","volume":"41","author":"LL Chen","year":"2016","unstructured":"Chen LL. Linking long noncoding RNA localization and function. Trends Biochem Sci. 2016;41:761\u2013772.","journal-title":"Trends Biochem Sci"},{"key":"6690_CR36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bbrc.2019.04.108","volume":"513","author":"T Wang","year":"2019","unstructured":"Wang T, Wang X, Du Q, et al. The circRNA circP4HB promotes NSCLC aggressiveness and metastasis by sponging miR-133a-5p. Biochem Biophys Res Commun. 2019;513:904\u2013911.","journal-title":"Biochem Biophys Res Commun"},{"key":"6690_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000101320","volume":"185","author":"MI Kokkinos","year":"2007","unstructured":"Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW, Waltham M. Vimentin and epithelial-mesenchymal transition in human breast cancer\u2013observations in vitro and in vivo. Cells Tissues Organs. 2007;185:191\u2013203.","journal-title":"Cells Tissues Organs"},{"key":"6690_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1797","volume":"206","author":"E Korsching","year":"2005","unstructured":"Korsching E, Packeisen J, Liedtke C, et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol. 2005;206:451\u2013457.","journal-title":"J Pathol"},{"key":"6690_CR39","first-page":"90","volume":"3","author":"S Sethi","year":"2010","unstructured":"Sethi S, Macoska J, Chen W, Sarkar FH. Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res. 2010;3:90\u201399.","journal-title":"Am J Transl Res"},{"key":"6690_CR40","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/sj.bjc.6604713","volume":"99","author":"S Al-Saad","year":"2008","unstructured":"Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Br J Cancer. 2008;99:1476\u20131483.","journal-title":"Br J Cancer"},{"key":"6690_CR41","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/00000478-198608000-00006","volume":"10","author":"MP Upton","year":"1986","unstructured":"Upton MP, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimosato Y. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol. 1986;10:560\u2013567.","journal-title":"Am J Surg Pathol"},{"key":"6690_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000163895","volume":"62","author":"K Takemura","year":"1994","unstructured":"Takemura K, Hirayama R, Hirokawa K, et al. Expression of vimentin in gastric cancer: a possible indicator for prognosis. Pathobiol J Immunopathol Mol Cell Biol. 1994;62:149\u2013154.","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"6690_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2220\/biomedres.31.105","volume":"31","author":"H Jin","year":"2010","unstructured":"Jin H, Morohashi S, Sato F, et al. Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res. 2010;31:105\u2013112.","journal-title":"Biomed Res"},{"key":"6690_CR44","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.onc.1206483","volume":"23","author":"L Hu","year":"2004","unstructured":"Hu L, Lau SH, Tzang CH, et al. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene. 2004;23:298\u2013302.","journal-title":"Oncogene"},{"key":"6690_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u2013629.","journal-title":"Nat Rev Clin Oncol"},{"key":"6690_CR46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u2013226.","journal-title":"Trends Cell Biol"},{"key":"6690_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-017-0685-9","volume":"16","author":"W Lu","year":"2017","unstructured":"Lu W, Zhang H, Niu Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer. 2017;16:118.","journal-title":"Mol Cancer"},{"key":"6690_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41419-019-1811-y","volume":"10","author":"Y Jia","year":"2019","unstructured":"Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019;10:573.","journal-title":"Cell Death Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06690-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06690-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T15:07:44Z","timestamp":1631977664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06690-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["6690"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06690-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study was approved by the ethics committee of Hebei Medical University Fourth Affiliated Hospital, and the informed consent was obtained from all of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients enrolled in this study have approved the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}